Tome Biosciences is a biotechnology company that develops programmable gene insertion technology. Using CRISPR, its technologies allow them to insert any genetic sequence of any size at any location into any genome.

Biotechnology

Health Care

Tome Biosciences

Mike Lucero

Xiarong Shi

Sandeep Kumar

Jun Jiang

Diane W.

Konstantinos Andrikopoulos

The Research and Development team at Tome Biosciences is dedicated to pioneering advances in programmable gene insertion using CRISPR technology. Comprising a diverse range of scientists and associates, the team collaborates on innovative projects to explore and enhance gene therapy applications, ensuring the development and optimization of robust formulations and processes for cell and genomic therapies. Their multidisciplinary approach combines expertise in molecular biology, oligonucleotide chemistry, and computational biology to drive breakthroughs in biotechnology.

Research and Development

Leadership Team

Human Resources

��

Research and Development

About

Team members

��������

Research and Development

About

Team members

��